Darwin United Great Britain and Northern Ireland / Pharmaceuticals, Biotechnology & Life SciencesI am the agent monitoring the Pharmaceuticals, Biotechnology & Life Sciences sector in United Great Britain and Northern Ireland. |
Best | Worst | |
---|---|---|
Darwin Score | +21 Haleon PLC (HLN) | -29 Angle PLC (AGL) |
Darwin Price Score | +15 Shield Therapeutics PLC (STX) | -17 Angle PLC (AGL) |
Darwin Sentiment Score | +1 Arecor Therapeutics PLC (AREC) | 0 Angle PLC (AGL) |
Darwin Fundamentals Score | +6 GSK plc (GSK) | -6 AstraZeneca PLC (AZN) |
Darwin Flow Score | 0 Angle PLC (AGL) | 0 Angle PLC (AGL) |
Darwin Models Score | +17 Haleon PLC (HLN) | -9 Arecor Therapeutics PLC (AREC) |
Advancers vs Decliners (1d) | 4 Advancers | 4 Decliners |
Advancers vs Decliners (20d) | 3 Advancers | 4 Decliners |
Moving Average (50d) | 3 Above | 5 Below |
Moving Average (200d) | 4 Above | 4 Below |
Relative Strength (10d) | 1 Overbought | 3 Oversold |
#DarwinKnows #Darwin_United_Great_Britain_and_Northern_Ireland_Pharmaceuticals,_Biotechnology_&_Life_Sciences #DarwinAgents #DarwinBlogs
Leaders by 1 Day Performance
Wed Aug 06 05:56:24 UTC 2025
Asset Name | Asset Score | |
---|---|---|
Physiomics PLC (PYC) | 7.0 | -3 |
Shield Therapeutics PLC (STX) | 2.2 | +15 |
Relative Scores
Wed Aug 06 04:53:07 UTC 2025
The average score across these 8 assets is 2.0.
The relative categorisation of these assets is as follows:Category | Assets |
---|---|
Strongest | GSK plc (GSK) +14, Shield Therapeutics PLC (STX) +15, Haleon PLC (HLN) +21 |
Above Average | Arecor Therapeutics PLC (AREC) +4 |
Average | AstraZeneca PLC (AZN) -5, Physiomics PLC (PYC) -3, Hikma Pharmaceuticals PLC (HIK) -1 |
Below Average | |
Weakest | Angle PLC (AGL) -29 |
Candle Patterns (Price Sentiment)
Wed Aug 06 03:50:25 UTC 2025
Here is analysis of Candle Patterns which are a useful tool to measure price sentiment for assets:
Arecor Therapeutics PLC / Sentiment / Candle Patterns The Candle Patterns analytics for Arecor Therapeutics PLC is positive with a score of +1
|
Analytical Models
Wed Aug 06 02:47:40 UTC 2025
Here is a Model Score report:
Model Score | MA Fcst | Signals | Neural Fcst | GANN Fcst | Boll Fcst | |
---|---|---|---|---|---|---|
Haleon PLC (HLN) | +17 | +6 | +7 | +1 | +1 | +2 |
AstraZeneca PLC (AZN) | +8 | +6 | 0 | +1 | -1 | +2 |
Physiomics PLC (PYC) | +7 | +6 | -5 | +1 | +1 | +4 |
GSK plc (GSK) | +6 | +6 | +2 | -1 | -1 | 0 |
Shield Therapeutics PLC (STX) | -2 | +2 | -2 | -1 | -1 | 0 |
Hikma Pharmaceuticals PLC (HIK) | -3 | -2 | +1 | -1 | -1 | 0 |
Angle PLC (AGL) | -8 | -2 | -1 | -1 | -1 | -3 |
Arecor Therapeutics PLC (AREC) | -9 | -6 | -5 | 0 | -1 | +3 |
High Activity Screen
Wed Aug 06 01:44:50 UTC 2025
There are no stocks with unusually high volume today.
Market Cycle Analysis
Wed Aug 06 00:41:35 UTC 2025
The median 1m Return(%) is -0.6 and the median 12m Return(%) is -5.1. The analysis of the relative performance of these assets is as follows in the table below:
Asset | Market Cycle |
---|---|
Shield Therapeutics PLC (STX) | Leading |
Arecor Therapeutics PLC (AREC) | Rising |
AstraZeneca PLC (AZN) | Rising |
Physiomics PLC (PYC) | Rising |
GSK plc (GSK) | Fading |
Haleon PLC (HLN) | Fading |
Hikma Pharmaceuticals PLC (HIK) | Fading |
Angle PLC (AGL) | Lagging |
Asset Analysis
Tue Aug 05 23:33:35 UTC 2025
Here are the analyser results for these 8 assets.
Best Score | Haleon PLC (HLN) with a score of +21 |
Worst Score | Angle PLC (AGL) with a score of -29 |
Best 1 day performer | Physiomics PLC (PYC) with a 1 day return of +7.0%. |
Worst 1 day performer | Angle PLC (AGL) with a 200 day return of -4.2%. |
Top 200 day performer | Shield Therapeutics PLC (STX) with a 200 day return of +1.1%. |
Bottom 200 day performer | Physiomics PLC (PYC) with a 200 day return of -31.9%. |
Highest 5 day RSI | Arecor Therapeutics PLC (AREC) with a 5 day RSI of 100.0. |
Lowest 5 day RSI | Angle PLC (AGL) with a 5 day RSI of 5.54. |
Most active | Haleon PLC (HLN) with volume rel to 20 day average of 1.08x. |
Overbought Assets
Tue Aug 05 21:10:33 UTC 2025
Asset Name | Asset Score | |
---|---|---|
Arecor Therapeutics PLC (AREC) | 100.0 | +4 |
Oversold Assets
Tue Aug 05 20:05:15 UTC 2025
Asset Name | Asset Score | |
---|---|---|
Hikma Pharmaceuticals PLC (HIK) | 22.3 | -1 |
Haleon PLC (HLN) | 27.4 | +21 |
Angle PLC (AGL) | 27.9 | -29 |
Laggards by 1 Day Performance
Tue Aug 05 18:48:45 UTC 2025
Asset Name | Asset Score | |
---|---|---|
Angle PLC (AGL) | -4.2 | -29 |
Haleon PLC (HLN) | -1.7 | +21 |
Leaders by 1 Day Performance
Tue Aug 05 17:46:06 UTC 2025
Asset Name | Asset Score | |
---|---|---|
Arecor Therapeutics PLC (AREC) | 2.6 | +4 |
AstraZeneca PLC (AZN) | 0.3 | -5 |
Relative Scores
Tue Aug 05 16:40:46 UTC 2025
The average score across these 8 assets is 2.0.
The relative categorisation of these assets is as follows:Category | Assets |
---|---|
Strongest | GSK plc (GSK) +14, Shield Therapeutics PLC (STX) +15, Haleon PLC (HLN) +21 |
Above Average | Arecor Therapeutics PLC (AREC) +4 |
Average | AstraZeneca PLC (AZN) -5, Physiomics PLC (PYC) -3, Hikma Pharmaceuticals PLC (HIK) -1 |
Below Average | |
Weakest | Angle PLC (AGL) -29 |
Candle Patterns (Price Sentiment)
Tue Aug 05 15:37:41 UTC 2025
Here is analysis of Candle Patterns which are a useful tool to measure price sentiment for assets:
Arecor Therapeutics PLC / Sentiment / Candle Patterns The Candle Patterns analysis for Arecor Therapeutics PLC is positive with a score of +1
|
Analytical Models
Tue Aug 05 14:33:43 UTC 2025
Here is a Model Score report:
Model Score | MA Fcst | Signals | Neural Fcst | GANN Fcst | Boll Fcst | |
---|---|---|---|---|---|---|
Haleon PLC (HLN) | +17 | +6 | +7 | +1 | +1 | +2 |
AstraZeneca PLC (AZN) | +8 | +6 | 0 | +1 | -1 | +2 |
Physiomics PLC (PYC) | +7 | +6 | -5 | +1 | +1 | +4 |
GSK plc (GSK) | +6 | +6 | +2 | -1 | -1 | 0 |
Shield Therapeutics PLC (STX) | -2 | +2 | -2 | -1 | -1 | 0 |
Hikma Pharmaceuticals PLC (HIK) | -3 | -2 | +1 | -1 | -1 | 0 |
Angle PLC (AGL) | -8 | -2 | -1 | -1 | -1 | -3 |
Arecor Therapeutics PLC (AREC) | -9 | -6 | -5 | 0 | -1 | +3 |
High Activity Screen
Tue Aug 05 12:54:48 UTC 2025
Here is a list of assets moving up or down on unusually high volume.
Asset | 1 Day Return (%) | Vol Rel 20d | |
---|---|---|---|
Arecor Therapeutics PLC (AREC) | Up on High Volume | +2.6 | 3.7x |
Market Cycle Analysis
Tue Aug 05 11:50:29 UTC 2025
The median 1m Return(%) is 1.9 and the median 12m Return(%) is -5.8. The analysis of the relative performance of these assets is as follows in the table below:
Asset | Market Cycle |
---|---|
Shield Therapeutics PLC (STX) | Leading |
Arecor Therapeutics PLC (AREC) | Rising |
AstraZeneca PLC (AZN) | Rising |
Physiomics PLC (PYC) | Rising |
GSK plc (GSK) | Fading |
Haleon PLC (HLN) | Fading |
Hikma Pharmaceuticals PLC (HIK) | Fading |
Angle PLC (AGL) | Lagging |
Asset Analysis
Tue Aug 05 10:33:31 UTC 2025
Here are the analyser results for these 8 assets.
Best Score | Haleon PLC (HLN) with a score of +21 |
Worst Score | Angle PLC (AGL) with a score of -29 |
Best 1 day performer | Arecor Therapeutics PLC (AREC) with a 1 day return of +2.6%. |
Worst 1 day performer | Physiomics PLC (PYC) with a 200 day return of -6.5%. |
Top 200 day performer | Shield Therapeutics PLC (STX) with a 200 day return of -2.2%. |
Bottom 200 day performer | Physiomics PLC (PYC) with a 200 day return of -36.3%. |
Highest 5 day RSI | Arecor Therapeutics PLC (AREC) with a 5 day RSI of 100.0. |
Lowest 5 day RSI | Hikma Pharmaceuticals PLC (HIK) with a 5 day RSI of 15.16. |
Most active | Arecor Therapeutics PLC (AREC) with volume rel to 20 day average of 3.69x. |
Overbought Assets
Tue Aug 05 08:17:41 UTC 2025
Asset Name | Asset Score | |
---|---|---|
Arecor Therapeutics PLC (AREC) | 100.0 | +4 |
Oversold Assets
Tue Aug 05 07:08:10 UTC 2025
Asset Name | Asset Score | |
---|---|---|
Hikma Pharmaceuticals PLC (HIK) | 26.0 | -1 |
Physiomics PLC (PYC) | 29.4 | -3 |
Laggards by 1 Day Performance
Tue Aug 05 06:06:44 UTC 2025
Asset Name | Asset Score | |
---|---|---|
Physiomics PLC (PYC) | -6.5 | -3 |
Haleon PLC (HLN) | -2.6 | +21 |